Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:26.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the study content and navigation with an error message and a Home link.
    Difference
    19%
    Check dated 2026-09-20T20:49:42.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now adds 'Type 2 diabetes' under related topics and includes a MedlinePlus Genetics entry in related topics. These additions provide quick access to broader background information about the condition and genetics related to the study area.
    Difference
    0.2%
    Check dated 2026-09-13T17:14:50.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page no longer displays Type 2 diabetes and the MedlinePlus Genetics related topics section. This reduces disease-specific context and associated background resources.
    Difference
    0.2%
    Check dated 2026-09-06T22:28:43.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page adds new related topics, including Type 2 diabetes and a MedlinePlus Genetics entry. The revision label updates from v3.6.5 to v3.6.6 to reflect a new version.
    Difference
    0.2%
    Check dated 2026-08-30T22:25:23.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Removed the related topics entries for Type 2 diabetes and MedlinePlus Genetics from the page. This change affects discoverability but not the core study details.
    Difference
    0.2%
    Check dated 2026-08-16T16:11:34.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.